A 5-year case series on Inflammatory Lichen Planopilaris treated with baricitinib

Nicole Kah Mun Yoong; Blake Smith; Lucy O’Reilly; Daniella Kushnir-Grinbaum; Rodney Sinclair

doi:10.1093/ced/llag127

March 12, 2026Clinical and Experimental Dermatology

A 5-year case series on Inflammatory Lichen Planopilaris treated with baricitinib

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the effectiveness of baricitinib in treating inflammatory lichen planopilaris over five years.
Case series design over five years
Focus on patients with inflammatory lichen planopilaris
Evaluation of baricitinib as a treatment
Observations indicate treatment improvements for lichen planopilaris
Lack of widely accepted treatment guidelines noted

Implication

Case series reports improvement in treatment for inflammatory lichen planopilaris, suggesting new guidelines may be needed.

Abstract

Lichen planopilaris (LPP) produces a chronic, progressive, multifocal, inflammatory cicatricial alopecia. There is currently no highly effective treatment for LPP of or widely accepted, treatment guidelines.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yoong et al. (2026) studied this question.

synapsesocial.com/papers/69b5ff8083145bc643d1c219 https://doi.org/10.1093/ced/llag127

View Full Paper

Ask AI

Bookmark

Share

A 5-year case series on Inflammatory Lichen Planopilaris treated with baricitinib

Key Points

Implication

Abstract

Discussion

Cite This Study

A 5-year case series on Inflammatory Lichen Planopilaris treated with baricitinib

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading